Clinical Trial

Analgesic Effectiveness of Capsaicin 8% Cutaneous Patch in Children

Study acronym: CAPSAPED
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study concerns children aged to 12 to 17-years with local chronic neuropathic pain after trauma or surgery. It is a multicentric randomized controlled superiority trial in parallel arms : * experimental arm: Capsaicin 8% cutaneous patch * controlled arm : Hydrocolloid dressing Treatment with capsaicin application is realized at baseline, and repeated 3 months after the first patch application if needed. Tolerance is assessed during each application and by phone call in following days until stop of cold need. Efficacy is assessed monthly by clinical consultation until the end of the study (month 4).
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2023-08-09; most recent amendment 2026-06-12.
Status change: Not Yet Recruiting → Recruiting 2024-03-20
Trial Details
NCT Number NCT05997979
Lead Sponsor University Hospital, Brest
Conditions Neuropathic Pain, Chronic Pain
Enrollment 46 participants
Start Date 2024-03-05
Primary Completion 2028-07-05 (estimated)
Study Completion 2028-07-05 (estimated)
Updated on ClinicalTrials.gov 2026-06-15